Overview

• Clinical trial participants saw up to a 10,000-fold increase in light sensitivity.
• The therapy, ATSN-101, was injected under the retina and tested in varying doses.
• Significant improvements in reading and navigation abilities were noted.
• Most side effects were minor and related to the surgical procedure.
• Further trials are planned to confirm safety and efficacy for broader use.